Viewing Study NCT00002504


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-02-08 @ 11:42 PM
Study NCT ID: NCT00002504
Status: COMPLETED
Last Update Posted: 2011-05-12
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Sponsor: Hoag Memorial Hospital Presbyterian
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
None Precancerous/Nonmalignant Condition View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV adult Hodgkin lymphoma View
None monoclonal gammopathy of undetermined significance View
None recurrent adult Hodgkin lymphoma View
None isolated plasmacytoma of bone View
None extramedullary plasmacytoma View
None refractory multiple myeloma View
None Waldenstrom macroglobulinemia View
None stage IV chronic lymphocytic leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None relapsing chronic myelogenous leukemia View
None refractory chronic lymphocytic leukemia View
None unspecified adult solid tumor, protocol specific View
None chronic phase chronic myelogenous leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None meningeal chronic myelogenous leukemia View
None untreated adult acute lymphoblastic leukemia View
None untreated adult acute myeloid leukemia View
None adult acute myeloid leukemia in remission View
None adult acute lymphoblastic leukemia in remission View
None polycythemia vera View
None chronic idiopathic myelofibrosis View
None essential thrombocythemia View
None untreated hairy cell leukemia View
None progressive hairy cell leukemia, initial treatment View
None refractory hairy cell leukemia View
None chronic myelomonocytic leukemia View
None T-cell large granular lymphocyte leukemia View
None acute undifferentiated leukemia View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV adult Burkitt lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None stage IV adult T-cell leukemia/lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None secondary acute myeloid leukemia View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None prolymphocytic leukemia View
None primary systemic amyloidosis View
None stage IV mantle cell lymphoma View
None recurrent mantle cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None anaplastic large cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View